CellSeed Inc. (TYO:7776)
Japan · Delayed Price · Currency is JPY 298.00
-4.00 (-1.32%)
Apr 17, 2026, 3:30 PM JST
CellSeed Market Cap
CellSeed has a market cap or net worth of 11.47 billion as of April 17, 2026. Its market cap has decreased by -25.51% in one year.
Market Cap
11.47B
Enterprise Value
n/a
Revenue
161.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
298.00
Market Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 11.47B, an increase of 117.84%. That is a compound annual growth rate of 4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 11.47B | 27.70% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 14.06B |
| Kidswell Bio | 12.40B |
| Nano Holdings | 12.06B |
| Kubota Pharmaceutical Holdings | 11.19B |
| OncoTherapy Science | 10.36B |
| K Pharma,Inc. | 8.80B |
| BrightPath Biotherapeutics | 8.78B |